Skip to content

The intervention study of the effects exerted by the electro-acupuncture stimulation of the upper limbs and lower limbs against cognitive decline · BPSD in early onset Alzheimer-type dementia

The intervention study of the effects exerted by the electro-acupuncture stimulation of the upper limbs and lower limbs against cognitive decline · BPSD in early onset Alzheimer-type dementia - The intervention study of the effects exerted by the electro-acupuncture stimulation of the upper limbs and lower limbs against cognitive decline · BPSD in early onset Alzheimer-type dementia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017936
Enrollment
5
Registered
2015-07-01
Start date
2015-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early onset Alzheimer-type dementia

Interventions

In addition to the standard treatment in the intervention period (two months), to perform the electro-acupuncture treatment.

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At the time of obtaining informed consent, age is less than 65 years of age or 40 years old patient 2. Has a memory impairment, aphasia, apraxia, agnosia, one or more of the cognitive impairment of the executive dysfunction 3. Outpatient 4. After receiving a sufficient explanation Upon participation in this study, on the understanding, a person who has obtained the consent in writing from the person or egally authorized representative

Exclusion criteria

Exclusion criteria: 1. Person who has caused cognitive dysfunction by cerebrovascular disease, central nervous system diseases such as Parkinson's disease 2. Person who has caused the cognitive dysfunction by systemic diseases such as hypothyroidism and folic acid deficiency 3. Person who has caused cognitive dysfunction due to substance-induced disease 4. Patients with metal allergy 5. Patients with the possibility of pregnant women and pregnancy or the patient during breast-feeding 6. Patients principal investigator has determined to be inappropriate as a subject

Design outcomes

Primary

MeasureTime frame
Change before and after treatment of MMSE

Countries

Japan

Contacts

Public ContactAkira Miura

Nagasaki University Hospital Department of Neuropsychiatry

miura@njs.ac.jp095-819-7293

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026